Literature DB >> 30778647

De-escalation of antimicrobial therapy in critically ill hematology patients: a prospective cohort study.

David Schnell1, Claire Montlahuc2, Fabrice Bruneel3, Matthieu Resche-Rigon2, Achille Kouatchet4, Jean-Ralph Zahar5, Michael Darmon1, Frédéric Pene6, Virginie Lemiale1, Antoine Rabbat7, François Vincent8, Elie Azoulay1, Djamel Mokart9.   

Abstract

Entities:  

Year:  2019        PMID： 30778647     DOI： 10.1007/s00134-019-05554-9

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  De-escalation of antimicrobial therapy for bacteraemia due to difficult-to-treat Gram-negative bacilli.

Authors:  N Shime; T Kosaka; N Fujita
Journal:  Infection       Date:  2012-12-20       Impact factor: 3.553

2.  De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial.

Authors:  Marc Leone; Carole Bechis; Karine Baumstarck; Jean-Yves Lefrant; Jacques Albanèse; Samir Jaber; Alain Lepape; Jean-Michel Constantin; Laurent Papazian; Nicolas Bruder; Bernard Allaouchiche; Karine Bézulier; François Antonini; Julien Textoris; Claude Martin
Journal:  Intensive Care Med       Date:  2014-08-05       Impact factor: 17.440

3.  De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study.

Authors:  Djamel Mokart; Géraldine Slehofer; Jérôme Lambert; Antoine Sannini; Laurent Chow-Chine; Jean-Paul Brun; Pierre Berger; Ségolène Duran; Marion Faucher; Jean-Louis Blache; Colombe Saillard; Norbert Vey; Marc Leone
Journal:  Intensive Care Med       Date:  2014-01       Impact factor: 17.440

4.  Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study.

Authors:  Elie Azoulay; Djamel Mokart; Frédéric Pène; Jérôme Lambert; Achille Kouatchet; Julien Mayaux; François Vincent; Martine Nyunga; Fabrice Bruneel; Louise-Marie Laisne; Antoine Rabbat; Christine Lebert; Pierre Perez; Marine Chaize; Anne Renault; Anne-Pascale Meert; Dominique Benoit; Rebecca Hamidfar; Mercé Jourdain; Michael Darmon; Benoit Schlemmer; Sylvie Chevret; Virginie Lemiale
Journal:  J Clin Oncol       Date:  2013-06-10       Impact factor: 44.544

5.  Antimicrobial de-escalation in septic cancer patients: is it safe to back down?

Authors:  Alla Paskovaty; Stephen M Pastores; Zivile Gedrimaite; Natalie Kostelecky; Elyn R Riedel; Susan K Seo
Journal:  Intensive Care Med       Date:  2015-08-22       Impact factor: 17.440
  5 in total
  2 in total

1.  Antimicrobial de-escalation is part of appropriate antibiotic usage in ICU.

Authors:  Jean-Francois Timsit; Jeffrey Lipman; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2020-02-20       Impact factor: 17.440

2.  Bloodstream infections in critically ill patients: an expert statement.

Authors:  Jean-François Timsit; Etienne Ruppé; François Barbier; Alexis Tabah; Matteo Bassetti
Journal:  Intensive Care Med       Date:  2020-02-11       Impact factor: 17.440
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.